Viewing Study NCT05668403


Ignite Creation Date: 2025-12-24 @ 7:49 PM
Ignite Modification Date: 2025-12-29 @ 6:25 AM
Study NCT ID: NCT05668403
Status: RECRUITING
Last Update Posted: 2025-02-10
First Post: 2022-12-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy
Sponsor: Shanghai Jiaolian Drug Research and Development Co., Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module